Are Concord Biotech latest results good or bad?
Concord Biotech's latest results are disappointing, with net sales dropping to Rs 203.99 crore and a significant decline in profit metrics, including a 52.6% decrease in Profit After Tax to Rs 44.06 crore, marking the lowest performance in five quarters.
Concord Biotech has reported its financial results for the quarter ending June 2025, which indicate a notable decline across several key metrics. The net sales for this quarter were recorded at Rs 203.99 crore, reflecting a significant decrease compared to the average net sales of Rs 300.02 crore over the previous four quarters. This marks the lowest sales figure in the last five quarters, suggesting a negative trend in sales performance.Profit Before Tax (PBT) also experienced a substantial decline, falling to Rs 45.05 crore, which is a significant reduction from the average PBT of Rs 112.53 crore in the prior four quarters. Similarly, Profit After Tax (PAT) decreased to Rs 44.06 crore, representing a decline of 52.6% and also the lowest figure in the last five quarters.
The operating profit was reported at Rs 61.40 crore, with an operating profit margin of 30.10%, both of which are the lowest observed in recent history. Additionally, earnings per share (EPS) fell to Rs 4.21, indicating a reduction in profitability and lower earnings for shareholders.
Overall, the financial results reflect a challenging quarter for Concord Biotech, and the company has seen an adjustment in its evaluation based on these outcomes.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
